(HAL) Halliburton - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US4062161017
Stock: Drilling Fluids, Well Tools, Chemicals, Logging, Bits
Total Rating 66
Risk 78
Buy Signal 0.36
| Risk 5d forecast | |
|---|---|
| Volatility | 31.1% |
| Relative Tail Risk | -4.11% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.95 |
| Alpha | 26.89 |
| Character TTM | |
|---|---|
| Beta | 1.084 |
| Beta Downside | 1.554 |
| Drawdowns 3y | |
|---|---|
| Max DD | 54.01% |
| CAGR/Max DD | 0.03 |
EPS (Earnings per Share)
Revenue
Description: HAL Halliburton March 04, 2026
Halliburton Company (HAL) provides diverse products and services to the global energy industry. The company operates through two primary segments: Completion and Production, and Drilling and Evaluation.
The Completion and Production segment focuses on services that enhance oil and gas well output. This includes stimulation, cementing, and completion tools. The segment also supplies electrical submersible pumps and offers artificial lift services, which are critical for maximizing production from mature wells. Additionally, it provides pipeline services and specialty chemicals, integral to the lifecycle of oil and gas infrastructure.
The Drilling and Evaluation segment supports the initial phases of oil and gas extraction. Its offerings include drilling fluid systems, drilling services, and wireline and perforating services for well logging. This segment also provides drill bits and digital solutions, including cloud-based AI for subsurface insights. These services are fundamental to the upstream oil and gas sector.
For more detailed financial analysis and performance metrics, continue your research on ValueRay.
Headlines to watch out for
- Oil and gas prices dictate drilling and completion activity
- Global E&P spending directly impacts service demand
- North American unconventional plays drive segment revenue
- International market expansion offers growth opportunities
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 1.28b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA -2.78 > 1.0 |
| NWC/Revenue: 26.19% < 20% (prev 27.60%; Δ -1.41% < -1%) |
| CFO/TA 0.12 > 3% & CFO 2.93b > Net Income 1.28b |
| Net Debt (5.93b) to EBITDA (3.30b): 1.79 < 3 |
| Current Ratio: 2.04 > 1.5 & < 3 |
| Outstanding Shares: last quarter (840.0m) vs 12m ago -4.87% < -2% |
| Gross Margin: 15.76% > 18% (prev 0.19%; Δ 1558 % > 0.5%) |
| Asset Turnover: 87.69% > 50% (prev 89.67%; Δ -1.98% > 0%) |
| Interest Coverage Ratio: 5.18 > 6 (EBITDA TTM 3.30b / Interest Expense TTM 418.0m) |
Altman Z'' 5.31
| A: 0.23 (Total Current Assets 11.40b - Total Current Liabilities 5.59b) / Total Assets 25.01b |
| B: 0.60 (Retained Earnings 15.04b / Total Assets 25.01b) |
| C: 0.09 (EBIT TTM 2.17b / Avg Total Assets 25.30b) |
| D: 1.19 (Book Value of Equity 17.33b / Total Liabilities 14.51b) |
| Altman-Z'' Score: 5.31 = AAA |
Beneish M -2.90
| DSRI: 1.00 (Receivables 4.94b/5.12b, Revenue 22.18b/22.94b) |
| GMI: 1.19 (GM 15.76% / 18.75%) |
| AQI: 1.07 (AQ_t 0.30 / AQ_t-1 0.28) |
| SGI: 0.97 (Revenue 22.18b / 22.94b) |
| TATA: -0.07 (NI 1.28b - CFO 2.93b) / TA 25.01b) |
| Beneish M-Score: -2.90 (Cap -4..+1) = A |
What is the price of HAL shares?
As of March 09, 2026, the stock is trading at USD 34.05 with a total of 18,533,096 shares traded.
Over the past week, the price has changed by -4.88%, over one month by -1.96%, over three months by +21.85% and over the past year by +40.55%.
Over the past week, the price has changed by -4.88%, over one month by -1.96%, over three months by +21.85% and over the past year by +40.55%.
Is HAL a buy, sell or hold?
Halliburton has received a consensus analysts rating of 4.10.
Therefore, it is recommended to buy HAL.
- StrongBuy: 12
- Buy: 8
- Hold: 9
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the HAL price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 36.5 | 7.2% |
| Analysts Target Price | 36.5 | 7.2% |
HAL Fundamental Data Overview March 07, 2026
P/E Trailing = 22.9262
P/E Forward = 15.0376
P/S = 1.296
P/B = 2.7566
P/EG = 11.4241
Revenue TTM = 22.18b USD
EBIT TTM = 2.17b USD
EBITDA TTM = 3.30b USD
Long Term Debt = 7.16b USD (from longTermDebt, last quarter)
Short Term Debt = 263.0m USD (from shortTermDebt, last quarter)
Debt = 8.13b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 5.93b USD (from netDebt column, last quarter)
Enterprise Value = 34.68b USD (28.75b + Debt 8.13b - CCE 2.21b)
Interest Coverage Ratio = 5.18 (Ebit TTM 2.17b / Interest Expense TTM 418.0m)
EV/FCF = 20.74x (Enterprise Value 34.68b / FCF TTM 1.67b)
FCF Yield = 4.82% (FCF TTM 1.67b / Enterprise Value 34.68b)
FCF Margin = 7.54% (FCF TTM 1.67b / Revenue TTM 22.18b)
Net Margin = 5.78% (Net Income TTM 1.28b / Revenue TTM 22.18b)
Gross Margin = 15.76% ((Revenue TTM 22.18b - Cost of Revenue TTM 18.69b) / Revenue TTM)
Gross Margin QoQ = 16.56% (prev 15.39%)
Tobins Q-Ratio = 1.39 (Enterprise Value 34.68b / Total Assets 25.01b)
Interest Expense / Debt = 1.06% (Interest Expense 86.0m / Debt 8.13b)
Taxrate = 7.24% (46.0m / 635.0m)
NOPAT = 2.01b (EBIT 2.17b * (1 - 7.24%))
Current Ratio = 2.04 (Total Current Assets 11.40b / Total Current Liabilities 5.59b)
Debt / Equity = 0.78 (Debt 8.13b / totalStockholderEquity, last quarter 10.46b)
Debt / EBITDA = 1.79 (Net Debt 5.93b / EBITDA 3.30b)
Debt / FCF = 3.54 (Net Debt 5.93b / FCF TTM 1.67b)
Total Stockholder Equity = 10.38b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.07% (Net Income 1.28b / Total Assets 25.01b)
RoE = 12.36% (Net Income TTM 1.28b / Total Stockholder Equity 10.38b)
RoCE = 12.35% (EBIT 2.17b / Capital Employed (Equity 10.38b + L.T.Debt 7.16b))
RoIC = 11.27% (NOPAT 2.01b / Invested Capital 17.83b)
WACC = 7.94% (E(28.75b)/V(36.88b) * Re(9.91%) + D(8.13b)/V(36.88b) * Rd(1.06%) * (1-Tc(0.07)))
Discount Rate = 9.91% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.23%
[DCF] Terminal Value 81.45% ; FCFF base≈1.97b ; Y1≈2.43b ; Y5≈4.14b
[DCF] Fair Price = 77.54 (EV 70.87b - Net Debt 5.93b = Equity 64.94b / Shares 837.5m; r=7.94% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 28.47 | EPS CAGR: 19.84% | SUE: 4.0 | # QB: 2
Revenue Correlation: 49.04 | Revenue CAGR: 7.70% | SUE: 2.01 | # QB: 4
EPS next Quarter (2026-06-30): EPS=0.53 | Chg7d=+0.000 | Chg30d=+0.001 | Revisions Net=+1 | Analysts=19
EPS current Year (2026-12-31): EPS=2.23 | Chg7d=+0.000 | Chg30d=-0.000 | Revisions Net=-4 | Growth EPS=-7.9% | Growth Revenue=-2.4%
EPS next Year (2027-12-31): EPS=2.69 | Chg7d=+0.000 | Chg30d=+0.005 | Revisions Net=+2 | Growth EPS=+20.6% | Growth Revenue=+3.9%
[Analyst] Revisions Ratio: +0.08 (7 Up / 6 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 5.5% (Discount Rate 9.9% - Earnings Yield 4.4%)
[Growth] Growth Spread = -7.9% (Analyst -2.3% - Implied 5.5%)
P/E Forward = 15.0376
P/S = 1.296
P/B = 2.7566
P/EG = 11.4241
Revenue TTM = 22.18b USD
EBIT TTM = 2.17b USD
EBITDA TTM = 3.30b USD
Long Term Debt = 7.16b USD (from longTermDebt, last quarter)
Short Term Debt = 263.0m USD (from shortTermDebt, last quarter)
Debt = 8.13b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 5.93b USD (from netDebt column, last quarter)
Enterprise Value = 34.68b USD (28.75b + Debt 8.13b - CCE 2.21b)
Interest Coverage Ratio = 5.18 (Ebit TTM 2.17b / Interest Expense TTM 418.0m)
EV/FCF = 20.74x (Enterprise Value 34.68b / FCF TTM 1.67b)
FCF Yield = 4.82% (FCF TTM 1.67b / Enterprise Value 34.68b)
FCF Margin = 7.54% (FCF TTM 1.67b / Revenue TTM 22.18b)
Net Margin = 5.78% (Net Income TTM 1.28b / Revenue TTM 22.18b)
Gross Margin = 15.76% ((Revenue TTM 22.18b - Cost of Revenue TTM 18.69b) / Revenue TTM)
Gross Margin QoQ = 16.56% (prev 15.39%)
Tobins Q-Ratio = 1.39 (Enterprise Value 34.68b / Total Assets 25.01b)
Interest Expense / Debt = 1.06% (Interest Expense 86.0m / Debt 8.13b)
Taxrate = 7.24% (46.0m / 635.0m)
NOPAT = 2.01b (EBIT 2.17b * (1 - 7.24%))
Current Ratio = 2.04 (Total Current Assets 11.40b / Total Current Liabilities 5.59b)
Debt / Equity = 0.78 (Debt 8.13b / totalStockholderEquity, last quarter 10.46b)
Debt / EBITDA = 1.79 (Net Debt 5.93b / EBITDA 3.30b)
Debt / FCF = 3.54 (Net Debt 5.93b / FCF TTM 1.67b)
Total Stockholder Equity = 10.38b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.07% (Net Income 1.28b / Total Assets 25.01b)
RoE = 12.36% (Net Income TTM 1.28b / Total Stockholder Equity 10.38b)
RoCE = 12.35% (EBIT 2.17b / Capital Employed (Equity 10.38b + L.T.Debt 7.16b))
RoIC = 11.27% (NOPAT 2.01b / Invested Capital 17.83b)
WACC = 7.94% (E(28.75b)/V(36.88b) * Re(9.91%) + D(8.13b)/V(36.88b) * Rd(1.06%) * (1-Tc(0.07)))
Discount Rate = 9.91% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.23%
[DCF] Terminal Value 81.45% ; FCFF base≈1.97b ; Y1≈2.43b ; Y5≈4.14b
[DCF] Fair Price = 77.54 (EV 70.87b - Net Debt 5.93b = Equity 64.94b / Shares 837.5m; r=7.94% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 28.47 | EPS CAGR: 19.84% | SUE: 4.0 | # QB: 2
Revenue Correlation: 49.04 | Revenue CAGR: 7.70% | SUE: 2.01 | # QB: 4
EPS next Quarter (2026-06-30): EPS=0.53 | Chg7d=+0.000 | Chg30d=+0.001 | Revisions Net=+1 | Analysts=19
EPS current Year (2026-12-31): EPS=2.23 | Chg7d=+0.000 | Chg30d=-0.000 | Revisions Net=-4 | Growth EPS=-7.9% | Growth Revenue=-2.4%
EPS next Year (2027-12-31): EPS=2.69 | Chg7d=+0.000 | Chg30d=+0.005 | Revisions Net=+2 | Growth EPS=+20.6% | Growth Revenue=+3.9%
[Analyst] Revisions Ratio: +0.08 (7 Up / 6 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 5.5% (Discount Rate 9.9% - Earnings Yield 4.4%)
[Growth] Growth Spread = -7.9% (Analyst -2.3% - Implied 5.5%)